FDA Votes 16-2 AGAINST Widespread Covid-19 Booster Shots
The Federal Drug Administration has voted 16-2 against a widespread Covid-19 booster shot program, stating that more data is needed.
The FDA’s Vaccines and Related Biological Products Advisory Committee held a hearing on Friday with scientists and Pfizer representatives, the latter of whom were pushing for a third “booster” dose of the company’s vaccine to the general public.
“While the agency hasn’t always followed the advice of its committee, it often does,” reported CNBC. “A final FDA decision could come in a matter of hours.”
“The Centers of Disease Control and Prevention has scheduled a two-day meeting next week to discuss plans to distribute the third shots in the U.S.”
The committee voted against Pfizer booster shots given to most Americans, but greenlit the shots to Americans over 65.
The vote isn’t entirely unexpected given public pushback against booster shots – pushback which was also occurring inside the government.
Earlier this month, it was reported that two senior FDA officials resigned over Biden’s plan to roll out Covid-19 booster shots before the agency even had an opportunity to review it.
“…Sources told Endpoints and Politico that Gruber and Krause were upset with Biden administration’s booster-shot plan,” according to Business Insider. “The administration announced last month that most people would be offered a COVID-19 booster shot about eight months after vaccination.”
A “state of emergency” that will leave unvaccinated Albertans essentially trapped inside their own homes.